SCHEMBL9109201

SCHEMBL9109201

ONc1cc(Cl)ccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ POLB P06746 1/20 0.55
▸ IDO1 P14902 1/20 0.52
▸ TSHR P16473 3/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ TP53 P04637 2/20 0.48
▸ MCL1 Q07820 1/20 0.47
▸ RAPGEF4 Q8WZA2 1/20 0.47
▸ EPHX1 P07099 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ PDK1 Q15118 1/20 0.43
▸ PDK2 Q15119 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30531906 1.00 MEN1 (0.55) MEN1KMT2APOLBIDO1TSHR
SCHEMBL11045353 0.80 ALDH1A1 (0.50) MEN1KMT2ATSHRHSD17B10ALDH1A1
SCHEMBL2681031 0.79 MEN1 (0.54) MEN1KMT2APOLBIDO1TSHR
SCHEMBL21026389 0.78 CA2 (0.39) MEN1KMT2APOLBIDO1ALDH1A1
SCHEMBL1275678 0.76 ALDH1A1 (0.40) KMT2AALDH1A1
SCHEMBL11287941 0.76 RAPGEF4 (0.55) POLBTSHRALDH1A1CYP3A4RAPGEF4
SCHEMBL11404618 0.76 PDK1 (0.47) MEN1KMT2AALDH1A1RAPGEF4MAPT
SCHEMBL1132624 0.75 IDO1 (0.57) MEN1KMT2APOLBIDO1TSHR
SCHEMBL29710420 0.75 IDO1 (0.57) MEN1KMT2APOLBIDO1TSHR
SCHEMBL1679559 0.75 RAPGEF4 (0.52) MEN1KMT2APOLBIDO1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023148380-A1 POWDER COATING COMPOSITION CINARTIS GMBH (DE) 2023-08-10 — — WO disclosed
EP-2480232-B1 DISUBSTITUTED ]4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES SANOFI SA (FR) 2013-10-02 — — EP disclosed
US-20120142735-A1 DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES SANOFI (FR) 2012-06-07 — — US disclosed
US-4224340-A Anti-inflammatory compositions containing α-phenyl-N-phenylnitrone compounds WILLIAM H. RORER, INC. (US) 1980-09-23 — — US disclosed
US-4214003-A ANTIINFLAMMATORY AGENTS WILLIAM H. RORER, INC. (US) 1980-07-22 — — US disclosed
US-4197314-A WITH A DIPHENYL NITRONE WILLIAM H. RORER, INC. (US) 1980-04-08 — — US disclosed
US-4153722-A ANTIINFLAMMATORY, A-PHENYL-N-PHENYLNITRONE WILLIAM H. RORER, INC. (US) 1979-05-08 — — US disclosed
US-3992395-A Process for the preparation of chlorinated phenylhydroxylamines RHONE-POULENC S.A. (FR) 1976-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142735-A1 DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES CMA1, TPSB2, TPSAB1 MEN1 1305/4885KMT2A 2228/4885POLB 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback